1. 3130 Prognostic value of ALK gene copy number in advanced Non Small Cell Lung Cancer (NSCLC) patients. (September 2015) Authors: Facchinetti, F.; Kalai, K.; Lueza, B.; Lacroix, L.; Pignon, J.P.; Valent, A.; Adam, J.; Auger, N.; Besse, B. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S646 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Circulating innate immune markers and outcomes in treatment-naïve advanced non–small cell lung cancer patients. (February 2019) Authors: Charrier, M.; Mezquita, L.; Lueza, B.; Dupraz, L.; Planchard, D.; Remon, J.; Caramella, C.; Cassard, L.; Boselli, L.; Reiners, K.S.; Pogge von Strandmann, E.; Rusakiewicz, S.; Ferrara, R.; Duchemann, B.; Naigeon, M.; Pignon, J.P.; Besse, B.; Chaput, N. Journal: European journal of cancer Issue: Volume 108(2019) Page Start: 88 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗